Contact this trialFirst, we need to learn more about you.
ACC inhibitor
Dual Drug Therapy for NASH with Fibrosis
Recruiting0 awardsPhase 2
Charleston, South Carolina
This trial is testing a new drug called PF-06865571 alone and with another drug, PF-05221304, on patients with NASH or liver fibrosis. The drugs aim to improve liver health by blocking enzymes that produce and store fat in the liver.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service